News Story: Full Text
Sponsored By
Cedars-Sinai Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website


Caution! Anti-EGFR Therapy May Endanger mCRC Patients (Colon / Recatal Cancer)

Al's Comment:

 Although this is for colon/ rectal cancer, we have to keep an eye on what is happening with all types of cancers.  This article talks about specific mutations in colon cancer that  make the tumor resistant to anti-EGFR therapy and some that actually make the tumor grow faster with anti-EGFR therapy.

   As far as I know this has never been looked at with brain tumors. EGFR is a major target for us, and things like that have to be looked at.



Posted on: 03/02/2014



Caution! Anti-EGFR Therapy May Endanger mCRC Patients

to view the story, you need to register with medscape.. click:

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557